Ranjan Duara

Ranjan Duara,

Department: Department of Neuroscience
Business Email: r.duara@ufl.edu

Publications

2024
Association of Physical Frailty and Cognitive Function in a Population-Based Cross-Sectional Study of American Older Adults.
Gerontology. 70(1):48-58 [DOI] 10.1159/000533919. [PMID] 37903474.
2024
Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment.
Frontiers in neurology. 15 [DOI] 10.3389/fneur.2024.1364658. [PMID] 38595851.
2024
Different aspects of failing to recover from proactive semantic interference predicts rate of progression from amnestic mild cognitive impairment to dementia.
Frontiers in aging neuroscience. 16 [DOI] 10.3389/fnagi.2024.1336008. [PMID] 38357533.
2024
Diffusion MRI relates to plasma Aβ42/40 in PET negative participants without dementia.
Alzheimer's & dementia : the journal of the Alzheimer's Association. [DOI] 10.1002/alz.13693. [PMID] 38441274.
2024
Free-water imaging reveals unique brain microstructural deficits in hispanic individuals with Dementia.
Brain imaging and behavior. 18(1):106-116 [DOI] 10.1007/s11682-023-00819-w. [PMID] 37903991.
2024
Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease.
Diagnostics (Basel, Switzerland). 14(7) [DOI] 10.3390/diagnostics14070704. [PMID] 38611617.
2024
Plasma Alzheimer’s biomarkers and brain amyloid in Hispanic and non-Hispanic older adults.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 20(1):437-446 [DOI] 10.1002/alz.13456. [PMID] 37671801.
2024
Sex significantly predicts medial temporal volume when controlling for the influence of ApoE4 biomarker and demographic variables: A cross-ethnic comparison.
Journal of the International Neuropsychological Society : JINS. 30(2):128-137 [DOI] 10.1017/S1355617723000358. [PMID] 37385978.
2023
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS).
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S98-S114 [DOI] 10.1002/alz.13453. [PMID] 37690109.
2023
Association of longitudinal cognitive decline with diffusion MRI in Gray Matter, Amyloid, and Tau deposition.
Neurobiology of aging. 121:166-178 [DOI] 10.1016/j.neurobiolaging.2022.10.013. [PMID] 36455492.
2023
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) cohort.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S42-S48 [DOI] 10.1002/alz.13344. [PMID] 37296082.
2023
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer’s Disease Study.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S115-S125 [DOI] 10.1002/alz.13399. [PMID] 37491668.
2023
Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2023.12.12.23299878. [PMID] 38168329.
2023
Creating the Pick’s disease International Consortium: Association study of MAPT H2 haplotype with risk of Pick’s disease.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2023.04.17.23288471. [PMID] 37163045.
2023
Cross-cultural Diagnostic Validity of the Multilingual Naming Test (MINT) in a Sample of Older Adults.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. [DOI] 10.1093/arclin/acad093. [PMID] 38123477.
2023
Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease.
NeuroImage. Clinical. 38 [DOI] 10.1016/j.nicl.2023.103437. [PMID] 37245492.
2023
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer’s disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S29-S41 [DOI] 10.1002/alz.13434. [PMID] 37653686.
2023
Learning slopes in early-onset Alzheimer’s disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S19-S28 [DOI] 10.1002/alz.13159. [PMID] 37243937.
2023
Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer’s Disease.
Journal of Alzheimer's disease : JAD. 93(2):495-507 [DOI] 10.3233/JAD-220624. [PMID] 37038809.
2023
Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK , GRB14 , and KIAA0825 as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2023.07.06.23292311. [PMID] 37461624.
2023
Pathogenic variants in the Longitudinal Early-onset Alzheimer’s Disease Study cohort.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S64-S73 [DOI] 10.1002/alz.13482. [PMID] 37801072.
2023
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) cohort near the midpoint of data collection.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S8-S18 [DOI] 10.1002/alz.13160. [PMID] 37256497.
2023
Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes.
Neurology. 101(14):e1412-e1423 [DOI] 10.1212/WNL.0000000000207685. [PMID] 37580158.
2023
Semantic intrusion errors are associated with plasma Ptau-181 among persons with amnestic mild cognitive impairment who are amyloid positive.
Frontiers in neurology. 14 [DOI] 10.3389/fneur.2023.1179205. [PMID] 37602238.
2023
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer’s disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S49-S63 [DOI] 10.1002/alz.13403. [PMID] 37496307.
2023
Stability in cognitive classification as a function of severity of impairment and ethnicity: A longitudinal analysis.
Applied neuropsychology. Adult. 1-14 [DOI] 10.1080/23279095.2023.2222861. [PMID] 37395391.
2023
The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer’s disease: A cross-sectional study.
Medicine. 102(24) [DOI] 10.1097/MD.0000000000034017. [PMID] 37327267.
2023
The Sporadic Early-onset Alzheimer’s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cohort.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S74-S88 [DOI] 10.1002/alz.13466. [PMID] 37850549.
2023
White matter hyperintensities are higher among early-onset Alzheimer’s disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer’s Disease Study (LEADS).
Alzheimer's & dementia : the journal of the Alzheimer's Association. 19 Suppl 9(Suppl 9):S89-S97 [DOI] 10.1002/alz.13402. [PMID] 37491599.
2022
A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non-converter Alzheimer’s disease subjects with consideration for their amyloid beta status.
Alzheimer's & dementia (Amsterdam, Netherlands). 14(1) [DOI] 10.1002/dad2.12258. [PMID] 35229014.
2022
A Tensorized Multitask Deep Learning Network for Progression Prediction of Alzheimer’s Disease.
Frontiers in aging neuroscience. 14 [DOI] 10.3389/fnagi.2022.810873. [PMID] 35601611.
2022
A transfer learning approach based on gradient boosting machine for diagnosis of Alzheimer’s disease.
Frontiers in aging neuroscience. 14 [DOI] 10.3389/fnagi.2022.966883. [PMID] 36275004.
2022
Association of Cognitive Impairment With Free Water in the Nucleus Basalis of Meynert and Locus Coeruleus to Transentorhinal Cortex Tract.
Neurology. 98(7):e700-e710 [DOI] 10.1212/WNL.0000000000013206. [PMID] 34906980.
2022
Associations Between Country where Education is Obtained and Cognitive Functioning Among South American and Caribbean Older Adults Living in the U.S.
Journal of cross-cultural gerontology. 37(3):257-274 [DOI] 10.1007/s10823-022-09456-0. [PMID] 36251109.
2022
Associations Between Vascular Risk Factors and Perivascular Spaces in Adults with Intact Cognition, Mild Cognitive Impairment, and Dementia.
Journal of Alzheimer's disease : JAD. 89(2):437-448 [DOI] 10.3233/JAD-215585. [PMID] 35871327.
2022
Cultural factors related to neuropsychological performance and brain atrophy among Hispanic older adults with amnestic Mild Cognitive Impairment (aMCI): A pilot study.
Applied neuropsychology. Adult. 29(3):364-372 [DOI] 10.1080/23279095.2020.1761368. [PMID] 32397837.
2022
Heterogeneity in Alzheimer’s Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 19(1):8-25 [DOI] 10.1007/s13311-022-01185-z. [PMID] 35084721.
2022
Phosphorylated tau sites that are elevated in Alzheimer’s disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain.
Alzheimer's & dementia : the journal of the Alzheimer's Association. [DOI] 10.1002/alz.12749. [PMID] 35920592.
2022
Semantic intrusion errors as a function of age, amyloid, and volumetric loss: a confirmatory path analysis.
International psychogeriatrics. 34(11):991-1001 [DOI] 10.1017/S1041610220004007. [PMID] 33455613.
2022
The association of depression and apathy with Alzheimer’s disease biomarkers in a cross-cultural sample.
Applied neuropsychology. Adult. 1-17 [DOI] 10.1080/23279095.2022.2079414. [PMID] 35764422.
2022
The Broad Range of Research in Alzheimer’s Disease and Related Dementias.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 19(1):1-7 [DOI] 10.1007/s13311-022-01245-4. [PMID] 35562636.
2022
The effect of acculturation on cognitive performance among older Hispanics in the United States.
Applied neuropsychology. Adult. 29(2):163-171 [DOI] 10.1080/23279095.2020.1725888. [PMID] 32116033.
2021
Baseline Neuroimaging Predicts Decline to Dementia From Amnestic Mild Cognitive Impairment.
Frontiers in aging neuroscience. 13 [DOI] 10.3389/fnagi.2021.758298. [PMID] 34950021.
2021
Changes in LASSI-L performance over time among older adults with amnestic MCI and amyloid positivity: A preliminary study.
Journal of psychiatric research. 143:98-105 [DOI] 10.1016/j.jpsychires.2021.08.033. [PMID] 34464879.
2021
Depression and the Diagnosis of MCI in a Culturally Diverse Sample in the United States.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 36(2):214-230 [DOI] 10.1093/arclin/acz043. [PMID] 31729523.
2021
Intrusion Errors and Progression of Cognitive Deficits in Older Adults with Mild Cognitive Impairment and PreMCI States.
Dementia and geriatric cognitive disorders. 50(2):135-142 [DOI] 10.1159/000512804. [PMID] 34161947.
2021
Mild behavioral impairment as a predictor of cognitive functioning in older adults.
International psychogeriatrics. 33(3):285-293 [DOI] 10.1017/S1041610220000678. [PMID] 32456733.
2021
PET Imaging of Tau Pathology and Amyloid-β, and MRI for Alzheimer’s Disease Feature Fusion and Multimodal Classification.
Journal of Alzheimer's disease : JAD. 84(4):1497-1514 [DOI] 10.3233/JAD-210064. [PMID] 34719488.
2021
The Association Between Functional Assessment and Structural Brain Biomarkers in an Ethnically Diverse Sample With Normal Cognition, Mild Cognitive Impairment, or Dementia.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 36(1):51-61 [DOI] 10.1093/arclin/acaa065. [PMID] 32890393.
2021
The relationship of semantic intrusions to different etiological subtypes of MCI and cognitively healthy older adults.
Alzheimer's & dementia (Amsterdam, Netherlands). 13(1) [DOI] 10.1002/dad2.12192. [PMID] 34084887.
2021
Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease.
Nature communications. 12(1) [DOI] 10.1038/s41467-021-22399-3. [PMID] 33875655.
2021
Utility of Plasma Neurofilament Light in the 1Florida Alzheimer’s Disease Research Center (ADRC).
Journal of Alzheimer's disease : JAD. 79(1):59-70 [DOI] 10.3233/JAD-200901. [PMID] 33216030.
2020
A Brief Version of the LASSI-L Detects Prodromal Alzheimer’s Disease States.
Journal of Alzheimer's disease : JAD. 78(2):789-799 [DOI] 10.3233/JAD-200790. [PMID] 33074233.
2020
A distributed multitask multimodal approach for the prediction of Alzheimer’s disease in a longitudinal study.
NeuroImage. 206 [DOI] 10.1016/j.neuroimage.2019.116317. [PMID] 31678502.
2020
A Gaussian-based model for early detection of mild cognitive impairment using multimodal neuroimaging.
Journal of neuroscience methods. 333 [DOI] 10.1016/j.jneumeth.2019.108544. [PMID] 31838182.
2020
A novel method of evaluating semantic intrusion errors to distinguish between amyloid positive and negative groups on the Alzheimer’s disease continuum.
Journal of psychiatric research. 124:131-136 [DOI] 10.1016/j.jpsychires.2020.02.008. [PMID] 32146222.
2020
Clinical and pathologic features of cognitive-predominant corticobasal degeneration.
Neurology. 95(1):e35-e45 [DOI] 10.1212/WNL.0000000000009734. [PMID] 32518146.
2020
Gaussian discriminative component analysis for early detection of Alzheimer’s disease: A supervised dimensionality reduction algorithm.
Journal of neuroscience methods. 344 [DOI] 10.1016/j.jneumeth.2020.108856. [PMID] 32663548.
2020
Global Vascular Risk Score and CAIDE Dementia Risk Score Predict Cognitive Function in the Northern Manhattan Study.
Journal of Alzheimer's disease : JAD. 73(3):1221-1231 [DOI] 10.3233/JAD-190925. [PMID] 31884476.
2020
Multimodality Imaging of Dementia: Clinical Importance and Role of Integrated Anatomic and Molecular Imaging.
Radiographics : a review publication of the Radiological Society of North America, Inc. 40(1):200-222 [DOI] 10.1148/rg.2020190070. [PMID] 31917652.
2020
Neuropsychiatric symptoms as a distinguishing factor between memory diagnoses.
International journal of geriatric psychiatry. 35(10):1115-1122 [DOI] 10.1002/gps.5333. [PMID] 32391573.
2020
Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
JAMA neurology. 77(2):225-233 [DOI] 10.1001/jamaneurol.2019.3606. [PMID] 31657834.
2019
A clinically-translatable machine learning algorithm for the prediction of Alzheimer’s disease conversion: further evidence of its accuracy via a transfer learning approach.
International psychogeriatrics. 31(7):937-945 [DOI] 10.1017/S1041610218001618. [PMID] 30426918.
2019
A cognitive stress test for prodromal Alzheimer’s disease: Multiethnic generalizability.
Alzheimer's & dementia (Amsterdam, Netherlands). 11:550-559 [DOI] 10.1016/j.dadm.2019.05.003. [PMID] 31417955.
2019
A survey on applications and analysis methods of functional magnetic resonance imaging for Alzheimer’s disease.
Journal of neuroscience methods. 317:121-140 [DOI] 10.1016/j.jneumeth.2018.12.012. [PMID] 30593787.
2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Nature genetics. 51(9):1423-1424 [DOI] 10.1038/s41588-019-0495-7. [PMID] 31417202.
2019
Clinicopathologic subtype of Alzheimer’s disease presenting as corticobasal syndrome.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 15(9):1218-1228 [DOI] 10.1016/j.jalz.2019.04.011. [PMID] 31399334.
2019
Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity.
NeuroImage. Clinical. 22 [DOI] 10.1016/j.nicl.2019.101800. [PMID] 30991618.
2019
Effects of Bilingualism on Verbal and Nonverbal Memory Measures in Mild Cognitive Impairment.
Journal of the International Neuropsychological Society : JINS. 25(1):15-28 [DOI] 10.1017/S135561771800070X. [PMID] 30334507.
2019
Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 15(5):635-643 [DOI] 10.1016/j.jalz.2018.12.013. [PMID] 30792090.
2019
Factors influencing attrition in 35 Alzheimer’s Disease Centers across the USA: a longitudinal examination of the National Alzheimer’s Coordinating Center’s Uniform Data Set.
Aging clinical and experimental research. 31(9):1283-1297 [DOI] 10.1007/s40520-018-1087-6. [PMID] 30535620.
2019
Free-water imaging of the hippocampus is a sensitive marker of Alzheimer’s disease.
NeuroImage. Clinical. 24 [DOI] 10.1016/j.nicl.2019.101985. [PMID] 31470214.
2019
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Nature genetics. 51(3):414-430 [DOI] 10.1038/s41588-019-0358-2. [PMID] 30820047.
2019
Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer’s Disease, Independent of Amyloid Load and APOE Genotype.
Journal of Alzheimer's disease : JAD. 69(1):145-156 [DOI] 10.3233/JAD-180231. [PMID] 30958345.
2019
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society. 34(11):1655-1662 [DOI] 10.1002/mds.27816. [PMID] 31433871.
2019
The prognostic value of ATN Alzheimer biomarker profiles in cognitively normal individuals.
Neurology. 92(14):643-644 [DOI] 10.1212/WNL.0000000000007223. [PMID] 30842299.
2019
Types of errors on a semantic interference task in mild cognitive impairment and dementia.
Neuropsychology. 33(5):670-684 [DOI] 10.1037/neu0000542. [PMID] 31070384.
2018
A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer’s Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.
Journal of Alzheimer's disease : JAD. 61(4):1555-1573 [DOI] 10.3233/JAD-170547. [PMID] 29355115.
2018
A Neuroimaging Web Services Interface as a Cyber Physical System for Medical Imaging and Data Management in Brain Research: Design Study.
JMIR medical informatics. 6(2) [DOI] 10.2196/medinform.9063. [PMID] 29699962.
2018
Gaussian Discriminant Analysis for Optimal Delineation of Mild Cognitive Impairment in Alzheimer’s Disease.
International journal of neural systems. 28(8) [DOI] 10.1142/S012906571850017X. [PMID] 29793369.
2018
Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis.
Journal of Alzheimer's disease : JAD. 64(1):323-335 [DOI] 10.3233/JAD-180239. [PMID] 29889075.
2018
Novel Cognitive Paradigms for the Detection of Memory Impairment in Preclinical Alzheimer’s Disease.
Assessment. 25(3):348-359 [DOI] 10.1177/1073191117691608. [PMID] 29214859.
2018
Relationship between Cognitive Performance and Measures of Neurodegeneration among Hispanic and White Non-Hispanic Individuals with Normal Cognition, Mild Cognitive Impairment, and Dementia.
Journal of the International Neuropsychological Society : JINS. 24(2):176-187 [DOI] 10.1017/S1355617717000820. [PMID] 28918757.
2018
Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness.
Current Alzheimer research. 15(9):848-855 [DOI] 10.2174/1567205015666180427122746. [PMID] 29701153.
2018
Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease.
Acta neuropathologica. 136(6):873-885 [DOI] 10.1007/s00401-018-1908-x. [PMID] 30219939.
2018
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
JAMA neurology. 75(9):1114-1123 [DOI] 10.1001/jamaneurol.2018.0894. [PMID] 29799984.
2018
Utility of Amyloid PET Scans in the Evaluation of Patients Presenting with Diverse Cognitive Complaints.
Journal of Alzheimer's disease : JAD. 66(4):1599-1608 [DOI] 10.3233/JAD-180683. [PMID] 30475766.
2018
Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.
Neurology. 91(10):e976-e984 [DOI] 10.1212/WNL.0000000000006128. [PMID] 30076274.
2017
African American exome sequencing identifies potential risk variants at Alzheimer disease loci.
Neurology. Genetics. 3(2) [DOI] 10.1212/NXG.0000000000000141. [PMID] 28480329.
2017
Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer’s Disease Genes in African Americans Identifies Novel PSEN Variants.
Journal of Alzheimer's disease : JAD. 56(4):1215-1222 [DOI] 10.3233/JAD-161185. [PMID] 28106563.
2017
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer’s disease.
Alzheimer's & dementia (Amsterdam, Netherlands). 9:25-34 [DOI] 10.1016/j.dadm.2017.06.001. [PMID] 28795133.
2017
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease.
Nature genetics. 49(9):1373-1384 [DOI] 10.1038/ng.3916. [PMID] 28714976.
2017
Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.
Journal of Alzheimer's disease : JAD. 59(1):131-139 [DOI] 10.3233/JAD-170276. [PMID] 28598850.
2017
Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer’s Disease.
Journal of Alzheimer's disease : JAD. 56(3):1119-1126 [DOI] 10.3233/JAD-160881. [PMID] 28106554.
2017
The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort.
Journal of Alzheimer's disease : JAD. 59(4):1269-1282 [DOI] 10.3233/JAD-170286. [PMID] 28731444.
2016
A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults.
Journal of Alzheimer's disease : JAD. 54(2):793-9 [DOI] 10.3233/JAD-160370. [PMID] 27567839.
2016
A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 24(10):804-13 [DOI] 10.1016/j.jagp.2016.02.056. [PMID] 27160985.
2016
The presenilin 1 p.Gly206Ala mutation is a frequent cause of early-onset Alzheimer’s disease in Hispanics in Florida.
American journal of neurodegenerative disease. 5(1):94-101 [PMID] 27073747.
2015
A practical guideline for intracranial volume estimation in patients with Alzheimer’s disease.
BMC bioinformatics. 16 Suppl 7(Suppl 7) [DOI] 10.1186/1471-2105-16-S7-S8. [PMID] 25953026.
2015
Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum.
Brain : a journal of neurology. 138(Pt 5):1370-81 [DOI] 10.1093/brain/awv050. [PMID] 25805643.
2015
Inclusion of Neuropsychological Scores in Atrophy Models Improves Diagnostic Classification of Alzheimer’s Disease and Mild Cognitive Impairment.
Computational intelligence and neuroscience. 2015 [DOI] 10.1155/2015/865265. [PMID] 26101520.
2015
Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.
JAMA neurology. 72(3):287-94 [DOI] 10.1001/jamaneurol.2014.4144. [PMID] 25622185.
2015
Proactive Semantic Interference is Associated with Total and Regional Abnormal Amyloid Load in Non-Demented Community-Dwelling Elders: A Preliminary Study.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 23(12):1276-1279 [DOI] 10.1016/j.jagp.2015.07.009. [PMID] 26525994.
2015
Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
JAMA neurology. 72(2):209-16 [DOI] 10.1001/jamaneurol.2014.2157. [PMID] 25531812.
2015
Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
International journal of geriatric psychiatry. 30(2):192-200 [DOI] 10.1002/gps.4126. [PMID] 24816477.
2015
Who wants a free brain scan? Assessing and correcting for recruitment biases in a population-based sMRI pilot study.
Brain imaging and behavior. 9(2):204-12 [DOI] 10.1007/s11682-014-9297-9. [PMID] 24573773.
2014
Altered small-world anatomical networks in Apolipoprotein-E4 (ApoE4) carriers using MRI.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2014:2468-71 [DOI] 10.1109/EMBC.2014.6944122. [PMID] 25570490.
2014
An optimal decisional space for the classification of Alzheimer’s disease and mild cognitive impairment.
IEEE transactions on bio-medical engineering. 61(8):2245-53 [DOI] 10.1109/TBME.2014.2310709. [PMID] 25051543.
2014
Comparative reliability analysis of publicly available software packages for automatic intracranial volume estimation.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2014:2342-5 [DOI] 10.1109/EMBC.2014.6944090. [PMID] 25570458.
2014
Differential clinicopathologic and genetic features of late-onset amnestic dementias.
Acta neuropathologica. 128(3):411-21 [DOI] 10.1007/s00401-014-1302-2. [PMID] 24899141.
2014
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.
JAMA neurology. 71(11):1394-404 [DOI] 10.1001/jamaneurol.2014.1491. [PMID] 25199842.
2014
Multivariate analysis of structural MRI and PET (FDG and 18F-AV-45) for Alzheimer’s disease and its prodromal stages.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2014:1051-4 [DOI] 10.1109/EMBC.2014.6943774. [PMID] 25570142.
2014
Significance of normalization on anatomical MRI measures in predicting Alzheimer’s disease.
TheScientificWorldJournal. 2014 [DOI] 10.1155/2014/541802. [PMID] 24550710.
2014
Verbal fluency patterns in mild cognitive impairment and Alzheimer’s disease.
Dementia and geriatric cognitive disorders. 38(1-2):1-9 [DOI] 10.1159/000355558. [PMID] 24556750.
2013
Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer’s disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 9(3):295-301 [DOI] 10.1016/j.jalz.2012.01.006. [PMID] 23178035.
2013
Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer’s disease.
Parkinsonism & related disorders. 19(2):227-31 [DOI] 10.1016/j.parkreldis.2012.10.013. [PMID] 23182311.
2013
The utility of age-specific cut-offs for visual rating of medial temporal atrophy in classifying Alzheimer’s disease, MCI and cognitively normal elderly subjects.
Frontiers in aging neuroscience. 5 [DOI] 10.3389/fnagi.2013.00047. [PMID] 24065917.
2012
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer’s and Lewy body pathology.
Journal of neurology, neurosurgery, and psychiatry. 83(4):424-9 [DOI] 10.1136/jnnp-2011-301413. [PMID] 22291217.
2012
An investigation of PreMCI: subtypes and longitudinal outcomes.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 8(3):172-9 [DOI] 10.1016/j.jalz.2011.03.002. [PMID] 22546351.
2012
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.
Proceedings of the National Academy of Sciences of the United States of America. 109(10):3985-90 [DOI] 10.1073/pnas.1105829109. [PMID] 22343285.
2012
Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer’s disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 8(3):211-8 [DOI] 10.1016/j.jalz.2011.04.008. [PMID] 22546353.
2012
Comparing new templates and atlas-based segmentations in the volumetric analysis of brain magnetic resonance images for diagnosing Alzheimer’s disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 8(5):399-406 [DOI] 10.1016/j.jalz.2011.07.002. [PMID] 22959698.
2012
Cross-validation of brain structural biomarkers and cognitive aging in a community-based study.
International psychogeriatrics. 24(7):1065-75 [DOI] 10.1017/S1041610212000191. [PMID] 22420888.
2012
High Blood caffeine levels in MCI linked to lack of progression to dementia.
Journal of Alzheimer's disease : JAD. 30(3):559-72 [DOI] 10.3233/JAD-2012-111781. [PMID] 22430531.
2012
Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia.
Acta neuropathologica. 124(5):681-92 [DOI] 10.1007/s00401-012-1044-y. [PMID] 22968369.
2012
Novel late-onset Alzheimer disease loci variants associate with brain gene expression.
Neurology. 79(3):221-8 [DOI] 10.1212/WNL.0b013e3182605801. [PMID] 22722634.
2011
Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Acta neuropathologica. 122(6):673-90 [DOI] 10.1007/s00401-011-0907-y. [PMID] 22083254.
2011
Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment.
Dementia and geriatric cognitive disorders. 31(4):276-83 [DOI] 10.1159/000324711. [PMID] 21494034.
2011
Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study.
The Lancet. Neurology. 10(9):785-96 [DOI] 10.1016/S1474-4422(11)70156-9. [PMID] 21802369.
2011
Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 19(11):951-60 [DOI] 10.1097/JGP.0b013e3182107c69. [PMID] 21422909.
2011
Reducing case ascertainment costs in U.S. population studies of Alzheimer’s disease, dementia, and cognitive impairment-Part 1.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 7(1):94-109 [DOI] 10.1016/j.jalz.2010.11.004. [PMID] 21255747.
2011
Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer’s disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 7(4):e101-8 [DOI] 10.1016/j.jalz.2010.07.002. [PMID] 21784342.
2010
Cross-validation of the Florida Cognitive Activities Scale (FCAS) in an Alzheimer’s disease research center sample.
Journal of geriatric psychiatry and neurology. 23(1):9-14 [DOI] 10.1177/0891988709342724. [PMID] 19703991.
2010
Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 18(8):684-91 [DOI] 10.1097/JGP.0b013e3181e56d5a. [PMID] 21399729.
2010
Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDR.
International journal of geriatric psychiatry. 25(3):282-9 [DOI] 10.1002/gps.2334. [PMID] 19565573.
2010
Maternal transmission of Alzheimer’s disease: prodromal metabolic phenotype and the search for genes.
Human genomics. 4(3):170-93 [PMID] 20368139.
2010
Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studies.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 18(4):363-70 [PMID] 20306566.
2010
The cognitive change checklist (3CL): cross-validation of a measure of change in everyday cognition.
International journal of geriatric psychiatry. 25(3):266-74 [DOI] 10.1002/gps.2332. [PMID] 19575419.
2010
The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer’s disease.
International journal of geriatric psychiatry. 25(5):511-8 [DOI] 10.1002/gps.2372. [PMID] 19750560.
2009
A comparative analysis of structural brain MRI in the diagnosis of Alzheimer’s disease.
Behavioural neurology. 21(1):13-9 [DOI] 10.3233/BEN-2009-0225. [PMID] 19847041.
2009
Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
AJNR. American journal of neuroradiology. 30(10):1870-6 [DOI] 10.3174/ajnr.A1693. [PMID] 19643919.
2009
Severity of medial temporal atrophy and amnestic mild cognitive impairment: selecting type and number of memory tests.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 17(12):1050-8 [DOI] 10.1097/JGP.0b013e3181b7ef42. [PMID] 20104061.
2009
Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period.
Dementia and geriatric cognitive disorders. 27(5):418-23 [DOI] 10.1159/000211803. [PMID] 19365121.
2009
The basis for disease-modifying treatments for Alzheimer’s disease: the Sixth Annual Mild Cognitive Impairment Symposium.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 5(1):66-74 [DOI] 10.1016/j.jalz.2008.10.006. [PMID] 19118811.
2009
The utility of a brief memory screen in the diagnosis of mild memory impairment in the elderly: preliminary study.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 17(5):437-40 [DOI] 10.1097/JGP.0b013e31819d3784. [PMID] 19390301.
2009
Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.
Journal of computer assisted tomography. 33(1):73-8 [DOI] 10.1097/RCT.0b013e31816373d8. [PMID] 19188789.
2008
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
Neurology. 71(24):1986-92 [DOI] 10.1212/01.wnl.0000336925.79704.9f. [PMID] 19064880.
2008
Patterns of depression in Spanish- and English-speaking patients with Alzheimer’s disease.
Journal of geriatric psychiatry and neurology. 21(1):47-55 [DOI] 10.1177/0891988707311564. [PMID] 18287170.
2008
Towards an earlier diagnosis of Alzheimer disease (Proceedings of the 5th MCI Symposium, 2007).
Alzheimer disease and associated disorders. 22(2):99-110 [DOI] 10.1097/WAD.0b013e3181630b93. [PMID] 18525280.
2007
Association studies between the plasmin genes and late-onset Alzheimer’s disease.
Neurobiology of aging. 28(7):1041-3 [PMID] 16828203.
2007
Influence of sociodemographic variables on neuropsychological test performance in Spanish-speaking older adults.
Journal of clinical and experimental neuropsychology. 29(5):530-44 [PMID] 17564918.
2007
Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
Journal of neuropathology and experimental neurology. 66(2):142-51 [PMID] 17278999.
2007
Stability of neurocognitive impairment in different subtypes of mild cognitive impairment.
Dementia and geriatric cognitive disorders. 23(2):82-6 [PMID] 17124415.
2007
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease.
Annals of neurology. 61(5):435-45 [PMID] 17469117.
2007
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.
Nature genetics. 39(2):168-77 [PMID] 17220890.
2007
The use of amnestic and nonamnestic composite measures at different thresholds in the neuropsychological diagnosis of MCI.
Journal of clinical and experimental neuropsychology. 29(3):300-7 [PMID] 17454350.
2007
Verbal fluency in bilingual Spanish/English Alzheimer’s disease patients.
American journal of Alzheimer's disease and other dementias. 22(3):190-201 [PMID] 17606528.
2007
Vulnerability to proactive semantic interference and progression to dementia among older adults with mild cognitive impairment.
Dementia and geriatric cognitive disorders. 24(5):363-8 [PMID] 17911981.
2006
Cognitive profiles in Alzheimer’s disease and in mild cognitive impairment of different etiologies.
Dementia and geriatric cognitive disorders. 21(5-6):309-15 [PMID] 16490966.
2006
Factors related to medication adherence in memory disorder clinic patients.
Aging & mental health. 10(4):378-85 [PMID] 16798630.
2006
Family history of dementia is a risk factor for Lewy body disease.
Neurology. 66(12):1949-50 [PMID] 16801670.
2006
The cyclooxygenase 2 -765 C promoter allele is a protective factor for Alzheimer’s disease.
Neuroscience letters. 395(3):240-3 [PMID] 16309832.
2006
Using different memory cutoffs to assess mild cognitive impairment.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 14(11):911-9 [PMID] 17068313.
2005
A clinical perspective of mild cognitive impairment: what radiologists should know.
Neuroimaging clinics of North America. 15(4):779-88, x [PMID] 16443490.
2005
The effect of a memory screening program on the early diagnosis of Alzheimer disease.
Alzheimer disease and associated disorders. 19(1):1-7 [PMID] 15764864.
2004
Apolipoprotein E polymorphism and age of onset for Alzheimer’s disease in a bi-ethnic sample.
International psychogeriatrics. 16(3):317-26 [PMID] 15559755.
2004
Cognitive rehabilitation of mildly impaired Alzheimer disease patients on cholinesterase inhibitors.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 12(4):395-402 [PMID] 15249277.
2004
Conversion to dementia among two groups with cognitive impairment. A preliminary report.
Dementia and geriatric cognitive disorders. 18(3-4):307-13 [PMID] 15305108.
2004
No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly.
International journal of geriatric psychiatry. 19(12):1131-9 [PMID] 15526312.
2004
Semantic interference deficits and the detection of mild Alzheimer’s disease and mild cognitive impairment without dementia.
Journal of the International Neuropsychological Society : JINS. 10(1):91-100 [PMID] 14751011.
2003
Depression as a risk factor for Alzheimer disease: the MIRAGE Study.
Archives of neurology. 60(5):753-9 [PMID] 12756140.
2003
Mild cognitive impairment: directions for future research.
Neurology. 61(4):438-44 [PMID] 12939414.
2003
Prevalence of dementia in three ethnic groups: the South Florida program on aging and health.
Annals of epidemiology. 13(6):472-8 [PMID] 12875807.
2003
Semantic interference in mild Alzheimer disease: preliminary findings.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 11(2):252-5 [PMID] 12611756.
2002
Apolipoprotein E genotype and cognitive impairment in community-dwelling black older adults.
International journal of psychiatry in medicine. 32(1):55-67 [PMID] 12075916.
2002
Apolipoprotein E polymorphism and cognitive impairment in a bi-ethnic community-dwelling elderly sample.
Alzheimer disease and associated disorders. 16(1):8-14 [PMID] 11882744.
2002
Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.
Alzheimer disease and associated disorders. 16(4):203-12 [PMID] 12468894.
2001
Association between Alzheimer’s disease and a functional polymorphism in the Myeloperoxidase gene.
Experimental neurology. 167(2):456-9 [PMID] 11161635.
2001
Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer’s disease.
Neurogenetics. 3(4):203-6 [PMID] 11714100.
2001
The Behavior Problems Checklist-Spanish: a preliminary study of a new scale for the assessment of depressive symptoms and disruptive behaviors in Hispanic patients with dementia.
International psychogeriatrics. 13(1):23-35 [PMID] 11352330.
2000
A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease.
Neurology. 55(6):763-8 [PMID] 10993992.
2000
Association between angiotensin-converting enzyme and Alzheimer disease.
Archives of neurology. 57(2):210-4 [PMID] 10681079.
2000
Category fluency test: normative data for English- and Spanish-speaking elderly.
Journal of the International Neuropsychological Society : JINS. 6(7):760-9 [PMID] 11105466.
2000
Clinical characteristics of community-dwelling black Alzheimer’s disease patients.
Journal of the National Medical Association. 92(9):424-9 [PMID] 11052455.
2000
Depressive symptoms in Alzheimer’s disease. An examination among community-dwelling Cuban American patients.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 8(1):84-91 [PMID] 10648299.
2000
Family history of dementia and current depression in nondemented community-dwelling older adults.
Journal of geriatric psychiatry and neurology. 13(2):65-71 [PMID] 10912727.
2000
Gender-specific association of the angiotensin converting enzyme gene with Alzheimer’s disease.
Neuroscience letters. 280(3):215-9 [PMID] 10675799.
2000
Head injury and the risk of AD in the MIRAGE study.
Neurology. 54(6):1316-23 [PMID] 10746604.
2000
No association between the NOS3 codon 298 polymorphism and Alzheimer’s disease in a sample from the United States.
Annals of neurology. 47(5) [PMID] 10805350.
2000
Predictors of anxiety in patients with Alzheimer’s disease.
Depression and anxiety. 11(1):38-42 [PMID] 10723634.
2000
Predictors of positive and negative appraisal among Cuban American caregivers of Alzheimer’s disease patients.
International journal of geriatric psychiatry. 15(6):481-7 [PMID] 10861912.
2000
Relationship of behavioral and psychological symptoms to cognitive impairment and functional status in Alzheimer’s disease.
International journal of geriatric psychiatry. 15(5):393-400 [PMID] 10822237.
2000
The genetic association between Cathepsin D and Alzheimer’s disease.
Neuroscience letters. 289(1):61-5 [PMID] 10899409.
2000
Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders.
International journal of geriatric psychiatry. 15(5):434-40 [PMID] 10822242.
1999
A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics.
Neurology. 52(3):551-6 [PMID] 10025786.
1999
Alzheimers disease is not associated with the hypertension genetic risk factors PLA(2) or G protein beta3, either independently or interactively with apolipoprotein E.
American journal of medical genetics. 88(5):465-8 [PMID] 10490699.
1999
Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer’s disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 7(2):119-23 [PMID] 10322238.
1999
Association between premorbid history of depression and current depression in Alzheimer’s disease.
Journal of geriatric psychiatry and neurology. 12(2):72-5 [PMID] 10483928.
1999
Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency.
American journal of medical genetics. 88(5):458-61 [PMID] 10490697.
1999
Diffuse Lewy body disease: clinical, pathological, and neuropsychological review.
Neuropsychology review. 9(3):137-50 [PMID] 10565674.
1999
Factors associated with depressive symptoms in non-demented community-dwelling elderly.
International journal of geriatric psychiatry. 14(5):331-7 [PMID] 10389035.
1999
Frontotemporal dementia and Alzheimer’s disease: differential diagnosis.
Dementia and geriatric cognitive disorders. 10 Suppl 1:37-42 [PMID] 10436338.
1999
No genetic association between polymorphisms in the Tau gene and Alzheimer’s disease in clinic or population based samples.
Neuroscience letters. 266(3):193-6 [PMID] 10465706.
1999
Prevalence and correlates of Capgras syndrome in Alzheimer’s disease.
International journal of geriatric psychiatry. 14(6):415-20 [PMID] 10398349.
1999
Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample.
International journal of geriatric psychiatry. 14(7):526-33 [PMID] 10440972.
1999
The alpha-2 macroglobulin gene is not associated with Alzheimer’s disease in a case-control sample.
Neuroscience letters. 270(3):133-6 [PMID] 10462112.
1998
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.
Neuroscience letters. 250(3):189-92 [PMID] 9708864.
1998
Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease.
Human molecular genetics. 7(5):933-5 [PMID] 9536099.
1998
Association between bleomycin hydrolase and Alzheimer’s disease in caucasians.
Annals of neurology. 44(5):808-11 [PMID] 9818937.
1998
Depressive symptomatology in first-degree family caregivers of Alzheimer disease patients: a cross-ethnic comparison.
Alzheimer disease and associated disorders. 12(4):340-6 [PMID] 9876963.
1998
Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity.
JAMA. 280(7):614-8 [PMID] 9718052.
1998
The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer’s disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
Neuroscience letters. 252(2):95-8 [PMID] 9756330.
1998
The APOE-epsilon4 allele and Alzheimer disease among African Americans, Hispanics, and whites.
JAMA. 280(19):1661-2; author reply 1663 [PMID] 9831992.
1998
The behavioral pathology in Alzheimer’s Disease Scale (BEHAVE-AD): factor structure among community-dwelling Alzheimer’s disease patients.
International journal of geriatric psychiatry. 13(11):793-800 [PMID] 9850876.
1998
The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.
Neuroscience letters. 249(2-3):115-8 [PMID] 9682830.
1998
The factor structure of the Cornell Scale for Depression in Dementia among probable Alzheimer’s disease patients.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 6(3):212-20 [PMID] 9659954.
1997
APOE is linked to Alzheimer’s disease in a large pedigree.
American journal of medical genetics. 74(4):365-9 [PMID] 9259370.
1997
Interfamilial and intrafamilial phenotypic heterogeneity in familial Alzheimer’s disease.
Journal of geriatric psychiatry and neurology. 10(1):1-6 [PMID] 9100151.
1997
No association between apolipoprotein E genotype and late-onset depression in Alzheimer’s disease.
Biological psychiatry. 41(2):246-8 [PMID] 9018400.
1997
No association between the intronic presenilin-1 polymorphism and Alzheimer’s disease in clinic and population-based samples.
American journal of medical genetics. 74(2):202-3 [PMID] 9129725.
1997
No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer’s disease in a community-based sample.
Neuroscience letters. 233(2-3):145-7 [PMID] 9350853.
1997
No association between the very low density lipoprotein receptor gene and late-onset Alzheimer’s disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.
Genetic epidemiology. 14(3):299-305 [PMID] 9181358.
1996
Alzheimer’s disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset.
Neurology. 46(6):1575-9 [PMID] 8649551.
1996
Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.
American journal of human genetics. 59(3):664-75 [PMID] 8751868.
1996
Familial and population-based studies of apolipoprotein E and Alzheimer’s disease.
Annals of the New York Academy of Sciences. 802:16-26 [PMID] 8993480.
1996
Risk of dementia among relatives of Alzheimer’s disease patients in the MIRAGE study: What is in store for the oldest old?
Neurology. 46(3):641-50 [PMID] 8618660.
1995
Deterioration of functional capacities in Alzheimer’s disease after a 1-year period.
International psychogeriatrics. 7(4):495-503 [PMID] 8833273.
1995
Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer’s Disease but is not causative.
American journal of medical genetics. 60(1):1-6 [PMID] 7485228.
1995
Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 10(2):75-88 [PMID] 14589730.
1995
South Florida Program on Aging and Health. Assessing the prevalence of Alzheimer’s disease in three ethnic groups.
The Journal of the Florida Medical Association. 82(12):805-10 [PMID] 8568504.
1995
Use of the Fuld Object-Memory Evaluation in the Detection of Mild Dementia Among Spanish and English-Speaking Groups.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 3(4):300-307 [DOI] 10.1097/00019442-199503040-00004. [PMID] 28531063.
1994
Apperceptive visual agnosia: a case study.
Brain and cognition. 25(1):1-23 [PMID] 8043261.
1994
Neural-network classification of normal and Alzheimer’s disease subjects using high-resolution and low-resolution PET cameras.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 35(1):7-15 [PMID] 8271062.
1993
A comparative analysis of neuropsychological test performance of Spanish-speaking and English-speaking patients with Alzheimer’s disease.
Journal of gerontology. 48(3):P142-9 [PMID] 8482824.
1993
A comparison of familial and sporadic Alzheimer’s disease.
Neurology. 43(7):1377-84 [PMID] 8327141.
1993
Analysis of the c-FOS gene on chromosome 14 and the promoter of the amyloid precursor protein gene in familial Alzheimer’s disease.
Neurology. 43(11):2275-9 [PMID] 8232942.
1993
Temporal lobe surface area measurements on MRI in normal and dyslexic readers.
Neuropsychologia. 31(8):811-21 [PMID] 8413902.
1992
A comparative analysis of functional status among Spanish- and English-speaking patients with dementia.
Journal of gerontology. 47(6):P389-94 [PMID] 1430861.
1992
Evaluation of a neural-network classifier for PET scans of normal and Alzheimer’s disease subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 33(8):1459-67 [PMID] 1634935.
1992
Genetic evidence for a novel familial Alzheimer’s disease locus on chromosome 14.
Nature genetics. 2(4):330-4 [PMID] 1303289.
1992
Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 12(6):927-34 [PMID] 1400646.
1991
Cerebrocerebellar relationship during behavioral activation: a PET study.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 11(1):48-54 [PMID] 1984004.
1991
Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 32(9):1725-9 [PMID] 1880574.
1991
Neuroanatomic differences between dyslexic and normal readers on magnetic resonance imaging scans.
Archives of neurology. 48(4):410-6 [PMID] 2012516.
1991
Positron emission tomographic studies during serial word-reading by normal and dyslexic adults.
Journal of clinical and experimental neuropsychology. 13(4):531-44 [PMID] 1918284.
1991
The occurrence of different intrusive errors in patients with Alzheimer’s disease, multiple cerebral infarctions, and major depression.
Brain and cognition. 16(1):104-17 [PMID] 1854466.
1990
[Cerebral white matter bundle alterations in patients with dementia of Alzheimer type and patients with multi-infarct dementia–magnetic resonance imaging study].
Rinsho shinkeigaku = Clinical neurology. 30(1):110-2 [PMID] 2331816.
1990
Frontal hypermetabolism and thalamic hypometabolism in a patient with abnormal orienting and retrosplenial amnesia.
Neuropsychologia. 28(2):161-9 [PMID] 2314571.
1990
MR signal abnormalities in memory disorder and dementia.
AJNR. American journal of neuroradiology. 11(2):283-90 [PMID] 2107712.
1990
MR signal abnormalities in memory disorder and dementia.
AJR. American journal of roentgenology. 154(6):1285-92 [PMID] 2110743.
1989
[Cerebral white matter bundle measurements by magnetic resonance imaging].
Rinsho shinkeigaku = Clinical neurology. 29(4):513-6 [PMID] 2612107.
1989
[Size of the corpus callosum in normal subjects and patients with Alzheimer’s disease–magnetic resonance imaging study].
Rinsho shinkeigaku = Clinical neurology. 29(1):1-7 [PMID] 2743678.
1989
A new scale for the assessment of functional status in Alzheimer’s disease and related disorders.
Journal of gerontology. 44(4):P114-21 [PMID] 2738312.
1989
Asymmetric somatosensory activation with right- vs left-hand stimulation: a positron emission tomographic study.
Brain research. 483(2):355-60 [PMID] 2784991.
1989
Predominant left hemisphere metabolic dysfunction in dementia.
Archives of neurology. 46(2):146-52 [PMID] 2783845.
1989
Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer’s disease and multi-infarct dementia.
European neurology. 29 Suppl 3:9-15 [PMID] 2612532.
1989
Two behavioral states studied in a single PET/FDG procedure: error analysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 30(1):93-105 [PMID] 2783458.
1988
Cerebral metabolic effects of a verbal fluency test: a PET scan study.
Journal of clinical and experimental neuropsychology. 10(5):565-75 [PMID] 3265709.
1988
Dyslexia subtypes: genetics, behavior, and brain imaging.
Research publications – Association for Research in Nervous and Mental Disease. 66:139-47 [PMID] 3258668.
1988
Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 8(5):654-61 [PMID] 3417794.
1987
Behavioral activation and the variability of cerebral glucose metabolic measurements.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 7(3):266-71 [PMID] 3495545.
1987
Decline in cerebral glucose utilisation and cognitive function with aging in Down’s syndrome.
Journal of neurology, neurosurgery, and psychiatry. 50(6):766-74 [PMID] 2956363.
1987
Human task-specific somatosensory activation.
Neurology. 37(8):1301-8 [PMID] 3497363.
1987
Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer’s disease.
Brain research. 407(2):294-306 [PMID] 3494486.
1987
Relation of measured brain glucose utilisation and cerebral atrophy in man.
Journal of neurology, neurosurgery, and psychiatry. 50(6):779-85 [PMID] 3497229.
1987
Two behavioral states studied in a single PET/FDG procedure: theory, method, and preliminary results.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 28(5):852-60 [PMID] 3494830.
1986
Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
Annals of neurology. 19(1):60-7 [PMID] 3484930.
1986
Brain morphometry in autistic men as measured by volumetric computed tomography.
Archives of neurology. 43(7):669-72 [PMID] 3488051.
1986
Effects of fasting on ketone body concentrations in healthy men of different ages.
Journal of gerontology. 41(5):599-604 [PMID] 3489030.
1986
Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer’s-type dementia.
Archives of neurology. 43(9):882-5 [PMID] 3488728.
1986
Positron emission tomography in Alzheimer’s disease.
Neurology. 36(7):879-87 [PMID] 3487046.
1986
Relations among age, visual memory, and resting cerebral metabolism in 40 healthy men.
Brain and cognition. 5(4):412-27 [PMID] 3495280.
1985
Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer’s disease.
Neurology. 35(11):1556-61 [PMID] 3877253.
1985
Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography.
Archives of general psychiatry. 42(5):448-55 [PMID] 3872650.
1985
Clinical history, brain metabolism, and neuropsychological function in Alzheimer’s disease.
Annals of neurology. 18(3):298-309 [PMID] 3876805.
1985
Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer’s disease.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 5(2):193-200 [PMID] 3988821.
1984
Human brain glucose utilization and cognitive function in relation to age.
Annals of neurology. 16(6):703-13 [PMID] 6335379.
1984
Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 4(4):484-99 [PMID] 6501442.
1984
NIH Conference. Brain imaging: aging and dementia.
Annals of internal medicine. 101(3):355-69 [PMID] 6235763.
1984
Positron emission tomography in normal aging and Alzheimer’s disease.
Psychopharmacology bulletin. 20(3):466-71 [PMID] 6332332.
1983
Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years.
Brain : a journal of neurology. 106 (Pt 3):761-75 [PMID] 6605781.
1983
Down’s syndrome in adults: brain metabolism.
Science (New York, N.Y.). 221(4612):781-3 [PMID] 6224294.
1975
Prosopagnosia and associated disorders.
Neurology India. 23(3):149-55 [PMID] 1214960.

Contact Details

Emails:
Business:
r.duara@ufl.edu
Addresses:
Business Mailing:
PO Box 100236
GAINESVILLE FL 32610